Diabetes is a common metabolic disorder marked by unusually high plasma glucose levels,
which can lead to serious consequences such as retinopathy, diabetic neuropathy and …

Diabetes is a common metabolic disease characterized by abnormally high plasma glucose
levels, leading to major complications, such as diabetic neuropathy, retinopathy, and …

Type-2 diabetes mellitus is one of the most prevalent metabolic diseases in the world, and is
characterized by hyperglycemia (ie, high levels of glucose in the blood). Alpha-glucosidases …

Diabetes mellitus is a multifactorial global health disorder that is rising at an alarming rate.
Cardiovascular diseases, kidney damage and neuropathy are the main cause of high …

The inhibition of α-glucosidase and α-amylase, enzymes involved in the digestion of
carbohydrates, can significantly reduce the post-prandial increase of blood glucose and …

Background: Diabetes mellitus (DM) is a critical health issue prevailing in nearly half a
billion people worldwide. It is one of the most threatening metabolic diseases. Type 2 DM is …

Objective α-Glucosidase inhibitors can be used as a new class of antidiabetic drug. By
competitively inhibiting glycosidase activity, these inhibitors help to prevent the fast …

The rising predominance of type 2 diabetes, combined with the poor medical effects seen
with commercially available anti-diabetic medications, has motivated the development of …

The aim of this study is to collate all available data on antidiabetic plants that inhibit alpha
glucosidase, reported mainly by Medline (PubMed) these last years. In the present study …

Abstract Treatment of diabetes mellitus by oral α-glucosidase inhibitors is currently confined
to acarbose, miglitol and voglibose marred by efficacy problems and unwanted side effects …